Möchten Sie immer auf dem neuesten Stand bleiben?

Press release – No. 06 / 2019 Zealand Pharma to attend Needham Healthcare Conference Copenhagen, April 2, 2019 – Adam Steensberg, Interim Chief Executive Officer, and Marino Garcia, Senior Vice...

Company announcement – No. 09 / 2019 Total number of shares and voting rights in Zealand Pharma at March 31, 2019 Copenhagen, March 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a...

Company announcement – No. 8/2019 Zealand Pharma announces completion of the share subscription by Alexion Pharmaceuticals, Inc. and registration of capital increase               Zealand Pharma...

Company announcement – No. 7/2019 Zealand Pharma increases its share capital as a consequence of a new issue of shares               Zealand Pharma A/S' board of directors has exercised an...

Company announcement – No. 06 / 2019         Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases ...

Company announcement – No. 5 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, March 15, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...

Company Announcement – No. 04/2019 Zealand Pharma convenes its Annual General Meeting 2019 Copenhagen, March 12, 2019 – Zealand Pharma A/S ("Zealand") convenes the Company’s ordinary Annual General...

Company announcement – No. 03 / 2019 Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress Copenhagen, March 7, 2019 – Zealand Pharma A/S (“Zealand”)...

Press release – No. 04 / 2019 Zealand Pharma to attend Credit Suisse and BioCapital Healthcare Conferences Copenhagen, March 1, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend...

Company announcement – No. 02 / 2019 Zealand Pharma announces registration of executive management and an update of the Articles of Association Copenhagen, February 28, 2019 – Zealand Pharma A/S...